Insulin Other Hypoglycemic Drugs
Authors:
- Sara N. TrovingerSTSara N. Trovinger
- Sandra L. HrometzSHSandra L. Hrometz
- Sipan KeshishyanSKSipan Keshishyan
- Sidhartha D. RaySRSidhartha D. Ray
- 28 September 2016
- book chapter
- Published by Elsevier
- Vol. 38, 453-462
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetesAmerican Journal of Obstetrics and Gynecology, 2015
- Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority studyThe Lancet, 2015
- Insulin infusion therapy in critical care patients: Regular insulin vs short-acting insulin. A prospective, crossover, randomized, multicenter blind studyJournal of Critical Care, 2015
- Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country. A randomized control trialDiabetes Research and Clinical Practice, 2015
- Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trialDiabetes Research and Clinical Practice, 2015
- Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: The EASIE post-hoc analysis and extension trialJournal of Diabetes and its Complications, 2015
- Insulin degludec improves long‐term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal‐bolus insulin therapyDiabetes, Obesity and Metabolism, 2014
- Technosphere Insulin (Afrezza)Annals of Pharmacotherapy, 2014
- Modulation of insulin dose titration using a hypoglycaemia‐sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin‐naïve people with type 2 diabetesDiabetes, Obesity and Metabolism, 2014
- A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbationDiabetes/Metabolism Research and Reviews, 2014